Due to the rising prevalence of various blood disorders and growing patient awareness in this region, North America is anticipated to hold a significant Bleeding Disorders Treatment Market share in the blood disorder therapeutics market. The World Federation of Hemophilia estimates that over 11,000 Americans have von Willebrand disease and about 18,000 Americans have haemophilia.
Additionally, 400 newborns are diagnosed with haemophilia A each year, affecting 1 in 5,000 male births. The presence of a strong healthcare infrastructure and growing investments in research and development to create treatments for blood disorders are two additional factors that are substantially boosting regional market growth.
Read More:
https://knackersblogger.blogspot.com/2022/12/bleeding-disorders-treatment-market.html
